Form 8-K - Current report:
SEC Accession No. 0000950103-21-004449
Filing Date
2021-03-23
Accepted
2021-03-23 16:42:45
Documents
16
Period of Report
2021-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp148253_8k.htm   iXBRL 8-K 37503
2 EXHIBIT 4.1 dp148253_ex0401.htm EX-4.1 401486
3 EXHIBIT 4.2 dp148253_ex0402.htm EX-4.2 680743
4 EXHIBIT 99.1 dp148253_ex9901.htm EX-99.1 11423
5 GRAPHIC image_001.jpg GRAPHIC 3655
  Complete submission text file 0000950103-21-004449.txt   1508393

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crl-20210323.xsd EX-101.SCH 3178
7 XBRL LABEL FILE crl-20210323_lab.xml EX-101.LAB 34592
8 XBRL PRESENTATION FILE crl-20210323_pre.xml EX-101.PRE 22706
9 EXTRACTED XBRL INSTANCE DOCUMENT dp148253_8k_htm.xml XML 3705
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 21765299
SIC: 8731 Services-Commercial Physical & Biological Research